BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

57.13
USD
+1.47
(+2.64%)
0.38EPS
150.98P/E
11.07BMarket Cap
Feb 24Next Earn

BioMarin Pharmaceutical Inc. Documents

Q4 FY2022 · Presentation

BioMarin Pharmaceutical Inc - JPMorgan Healthcare Conference - Conference Call Deck · 34 pages

Read BioMarin Pharmaceutical Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2022 documents